China nationwide landscape of 16 types inherited metabolic disorders: a retrospective analysis on 372,255 clinical cases.
Amino acids and acylcarnitines
China
Incidence and regional distributions
Inherited metabolic disorders
Organic acids
Journal
Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602
Informations de publication
Date de publication:
03 08 2023
03 08 2023
Historique:
received:
28
04
2023
accepted:
17
07
2023
medline:
7
8
2023
pubmed:
4
8
2023
entrez:
3
8
2023
Statut:
epublish
Résumé
Inherited metabolic disorders (IMDs) usually occurs at young age and hence it severely threatening the health and life of young people. While so far there lacks a comprehensive study which can reveals China's nationwide landscape of IMDs. This study aimed to evaluate IMDs incidence and regional distributions in China at a national and province level to guide clinicians and policy makers. The retrospective study conducted from January 2012 to March 2021, we analyzed and characterized 372255 cases' clinical test information and diagnostic data from KingMed Diagnostics Laboratory. The samples were from 32 provincial regions of China, the urine organic acids were detected by gas chromatography-mass spectrometry (GC-MS), amino acids and acylcarnitines in dried blood spots were detected by liquid chromatography-tandem mass spectrometry (LC-MS/MS). We did a statistical analysis of the distribution of the 16 most common IMDs in amino acid disorders and organic acidemias, and then paid special attention to analyze the age and regional distributions of different IMDs. The statistical analyses and visualization analysis were performed with the programming language R (version 4.2.1). There were 4911 positive cases diagnosed, which was 1.32% of the total sample during the ten-year study period. Most diseases tended to occur at ages younger than 18 year-old. The Ornithine Transcarbamylase Deficiency tended to progress on male infants who were less than 28 days old. While the peak of the positive case number of Citrin Deficiency disease (CD) was at 1-6 months. Different IMDs' had different distribution patterns in China's provinces. Methylmalonic Acidemias and Hyperphenylalaninemia had an imbalanced distribution pattern in China and its positive rate was significantly higher in North China than South China. Conversely, the positive rate of CD was significantly higher in South China than North China. Results of this work, such as the differences in distribution pattern of different diseases in terms of age, region, etc. provide important insights and references for clinicians, researchers and healthcare policy makers. The policy makers could optimize the better health screening programs for covering children and infants in specific ages and regions based on our findings.
Sections du résumé
BACKGROUND
Inherited metabolic disorders (IMDs) usually occurs at young age and hence it severely threatening the health and life of young people. While so far there lacks a comprehensive study which can reveals China's nationwide landscape of IMDs. This study aimed to evaluate IMDs incidence and regional distributions in China at a national and province level to guide clinicians and policy makers.
METHODS
The retrospective study conducted from January 2012 to March 2021, we analyzed and characterized 372255 cases' clinical test information and diagnostic data from KingMed Diagnostics Laboratory. The samples were from 32 provincial regions of China, the urine organic acids were detected by gas chromatography-mass spectrometry (GC-MS), amino acids and acylcarnitines in dried blood spots were detected by liquid chromatography-tandem mass spectrometry (LC-MS/MS). We did a statistical analysis of the distribution of the 16 most common IMDs in amino acid disorders and organic acidemias, and then paid special attention to analyze the age and regional distributions of different IMDs. The statistical analyses and visualization analysis were performed with the programming language R (version 4.2.1).
RESULTS
There were 4911 positive cases diagnosed, which was 1.32% of the total sample during the ten-year study period. Most diseases tended to occur at ages younger than 18 year-old. The Ornithine Transcarbamylase Deficiency tended to progress on male infants who were less than 28 days old. While the peak of the positive case number of Citrin Deficiency disease (CD) was at 1-6 months. Different IMDs' had different distribution patterns in China's provinces. Methylmalonic Acidemias and Hyperphenylalaninemia had an imbalanced distribution pattern in China and its positive rate was significantly higher in North China than South China. Conversely, the positive rate of CD was significantly higher in South China than North China.
CONCLUSIONS
Results of this work, such as the differences in distribution pattern of different diseases in terms of age, region, etc. provide important insights and references for clinicians, researchers and healthcare policy makers. The policy makers could optimize the better health screening programs for covering children and infants in specific ages and regions based on our findings.
Identifiants
pubmed: 37537594
doi: 10.1186/s13023-023-02834-y
pii: 10.1186/s13023-023-02834-y
pmc: PMC10398906
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
228Informations de copyright
© 2023. Institut National de la Santé et de la Recherche Médicale (INSERM).
Références
Zhao Z, Chen C, Sun X, Zhou D, Huang X, Dong H. Newborn screening for inherited metabolic diseases using tandem mass spectrometry in China: Outcome and cost-utility analysis. J Med Screen. 2022;29(1):12–20.
doi: 10.1177/09691413211021621
pubmed: 34102920
Yoon HR. Screening newborns for metabolic disorders based on targeted metabolomics using tandem mass spectrometry [published correction appears in Ann Pediatr Endocrinol Metab 2015 Dec;20(4):238]. Ann Pediatr Endocrinol Metab. 2015;20(3):119–124.
Boyer SW, Barclay LJ, Burrage LC. Inherited metabolic disorders: aspects of chronic nutrition management. Nutr Clin Pract. 2015;30(4):502–10.
doi: 10.1177/0884533615586201
pubmed: 26079521
pmcid: 4515158
Al-Dirbashi OY, Santa T, Al-Qahtani K, Al-Amoudi M, Rashed MS. Analysis of organic acid markers relevant to inherited metabolic diseases by ultra-performance liquid chromatography/tandem mass spectrometry as benzofurazan derivatives. Rapid Commun Mass Spectrom. 2007;21(13):1984–90.
doi: 10.1002/rcm.3053
pubmed: 17526065
Moat SJ, George RS, Carling RS. Use of dried blood spot specimens to monitor patients with inherited metabolic disorders. Int J Neonatal Screen. 2020;6(2):26.
doi: 10.3390/ijns6020026
pubmed: 33073023
pmcid: 7422991
Jones PM, Bennett MJ. Urine organic acid analysis for inherited metabolic disease using gas chromatography-mass spectrometry. Methods Mol Biol. 2010;603:423–31.
doi: 10.1007/978-1-60761-459-3_41
pubmed: 20077094
Sun W, Wang Y, Yang Y, et al. The screening of inborn errors of metabolism in sick Chinese infants by tandem mass spectrometry and gas chromatography/mass spectrometry. Clin Chim Acta. 2011;412(13–14):1270–4.
doi: 10.1016/j.cca.2011.03.028
pubmed: 21463612
Wasant P, Liammongkolkul S, Kuptanon C, Vatanavicharn N, Sathienkijakanchai A, Shinka T. Organic acid disorders detected by urine organic acid analysis: twelve cases in Thailand over three-year experience. Clin Chim Acta. 2008;392(1–2):63–8.
doi: 10.1016/j.cca.2008.02.015
Matsumoto I, Kuhara T. A new chemical diagnostic method for inborn errors of metabolism by mass spectrometry-rapid, practical, and simultaneous urinary metabolites analysis. Mass Spectrom Rev. 1996;15(1):43–57.
doi: 10.1002/(SICI)1098-2787(1996)15:1<43::AID-MAS3>3.0.CO;2-B
pubmed: 27082169
Phipps WS, Jones PM, Patel K. Amino and organic acid analysis: Essential tools in the diagnosis of inborn errors of metabolism. Adv Clin Chem. 2019;92:59–103.
doi: 10.1016/bs.acc.2019.04.001
pubmed: 31472756
Wajner M, Raymond K, Barschak A, et al. Detection of organic acidemias in Brazil. Arch Med Res. 2002;33(6):581–5.
doi: 10.1016/S0188-4409(02)00402-2
pubmed: 12505106
Tan IK, Gajra B, Lim MS. Study of inherited metabolic disorders in Singapore - 13 years experience. Ann Acad Med Singap. 2006;35(11):804–13.
doi: 10.47102/annals-acadmedsg.V35N11p804
pubmed: 17160197
Han L, Han F, Ye J, et al. Spectrum analysis of common inherited metabolic diseases in Chinese patients screened and diagnosed by tandem mass spectrometry. J Clin Lab Anal. 2015;29(2):162–8.
doi: 10.1002/jcla.21745
pubmed: 24797655
Hampe MH, Panaskar SN, Yadav AA, Ingale PW. Gas chromatography/mass spectrometry-based urine metabolome study in children for inborn errors of metabolism: an Indian experience. Clin Biochem. 2017;50(3):121–6.
doi: 10.1016/j.clinbiochem.2016.10.015
pubmed: 27784639
Lindner M, Gramer G, Haege G, et al. Efficacy and outcome of expanded newborn screening for metabolic diseases–report of 10 years from South-West Germany. Orphanet J Rare Dis. 2011;6:44.
doi: 10.1186/1750-1172-6-44
pubmed: 21689452
pmcid: 3141366
Li X, He J, He L, et al. Spectrum analysis of inherited metabolic disorders for expanded newborn screening in a central chinese population. Front Genet. 2022;12:763222.
doi: 10.3389/fgene.2021.763222
pubmed: 35095998
pmcid: 8790479
Tiivoja E, Reinson K, Muru K, et al. The prevalence of inherited metabolic disorders in Estonian population over 30 years: A significant increase during study period. JIMD Rep. 2022;63(6):604–13.
doi: 10.1002/jmd2.12325
pubmed: 36341167
pmcid: 9626666
von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495–9.
doi: 10.1016/j.ijsu.2014.07.013
Kimura M, Yamamoto T, Yamaguchi S. Automated metabolic profiling and interpretation of GC/MS data for organic acidemia screening: a personal computer-based system. Tohoku J Exp Med. 1999;188(4):317–34.
doi: 10.1620/tjem.188.317
pubmed: 10598689
Gallagher RC, Pollard L, Scott AI, et al. Laboratory analysis of organic acids, 2018 update: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2018;20(7):683–91.
doi: 10.1038/gim.2018.45
Nakagawa K, Kawana S, Hasegawa Y, Yamaguchi S. Simplified method for the chemical diagnosis of organic aciduria using GC/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2010;878(13–14):942–8.
doi: 10.1016/j.jchromb.2010.02.020
pubmed: 20303325
Han LS, Ye J, Qiu WJ, Gao XL, Wang Y, Gu XF. Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: a four-year report. J Inherit Metab Dis. 2007;30(4):507–14.
doi: 10.1007/s10545-007-0543-9
pubmed: 17347912
R Core Team (2022). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https://www.R-project.org/ . Accessed on 1st July 2022.
Alsharhan H, Alharbi H, Priestley J, Ganetzky R, He M. Urinary uracil: a useful marker for ornithine transcarbamylase deficiency in affected males. Clin Chem. 2020;66(7):988–9.
doi: 10.1093/clinchem/hvaa101
pubmed: 32628763
pmcid: 8132215
Toquet S, Spodenkiewicz M, Douillard C, et al. Adult-onset diagnosis of urea cycle disorders: results of a French cohort of 71 patients. J Inherit Metab Dis. 2021;44(5):1199–214.
doi: 10.1002/jimd.12403
pubmed: 34014557
Burgard P, Kölker S, Haege G, Lindner M, Hoffmann GF. Neonatal mortality and outcome at the end of the first year of life in early onset urea cycle disorders–review and meta-analysis of observational studies published over more than 35 years. J Inherit Metab Dis. 2016;39(2):219–29.
doi: 10.1007/s10545-015-9901-1
pubmed: 26634836
Writing Group For Practice Guidelines For Diagnosis And Treatment Of Genetic Diseases Medical Genetics Branch Of Chinese Medical Association, Huang S, Song F. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2020;37(3):226–234.
Sharabi AF, Goudar RB. Sources of power: Alkaptonuria. Treasure Island (FL): StatPearls Publishing; 2022.
Khaled A, Kerkeni N, Hawilo A, Fazaa B, Kamoun MR. Endogenous ochronosis: case report and a systematic review of the literature. Int J Dermatol. 2011;50(3):262–7.
doi: 10.1111/j.1365-4632.2010.04668.x
pubmed: 21342157
Kisa PT, Gunduz M, Dorum S, et al. Alkaptonuria in Turkey: clinical and molecular characteristics of 66 patients. Eur J Med Genet. 2021;64(5): 104197.
doi: 10.1016/j.ejmg.2021.104197
pubmed: 33746036
Lv T, Jia J. Rare liver diseases are not rare in China. Liver Int. 2022;42(9):2023–8.
doi: 10.1111/liv.15267
pubmed: 35365968
Song YZ, Zhang ZH, Lin WX, et al. SLC25A13 gene analysis in citrin deficiency: sixteen novel mutations in East Asian patients, and the mutation distribution in a large pediatric cohort in China. PLoS One. 2013;8(9):e74544.
doi: 10.1371/journal.pone.0074544
pubmed: 24069319
pmcid: 3777997
Baumgartner MR, Hörster F, Dionisi-Vici C, et al. Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. Orphanet J Rare Dis. 2014;9:130.
doi: 10.1186/s13023-014-0130-8
pubmed: 25205257
pmcid: 4180313
Xiang L, Tao J, Deng K, et al. Phenylketonuria incidence in China between 2013 and 2017 based on data from the Chinese newborn screening information system: a descriptive study [published correction appears in BMJ Open. 2020 Jan 10;10(1):e031474corr1]. BMJ Open. 2019;9(8):e031474
Jiang YZ, Shi Y, Shi Y, et al. Methylmalonic and propionic acidemia among hospitalized pediatric patients: a nationwide report. Orphanet J Rare Dis. 2019;14(1):292.
doi: 10.1186/s13023-019-1268-1
pubmed: 31842933
pmcid: 6915987